Nutra Pharma Corp. has reached a bifurcated settlement with the SEC along with its CEO and a Consultant to the company Coral Springs, Florida, March 22, 2024 - Nutra Pharma Corporation (OTC: NPHC), (“Nutra Pharma” or the “Company”) reached a settlement with the U.S. Securities and Exchange Commission (“SEC”) earlier this week. On March 19, 2024, the United States District Court for the Eastern District of New York in SEC v. Nutra Pharma Corporation, Erik Deitsch a/k/a Rik Deitsch, and Sean...